U.S. flag An official website of the United States government

U.S. Food and Drug Administration
  1. Home
  2. Drug Databases
  3. Drug Shortages

FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Report a Drug Shortage | FAQ | Background Info | Get Email Alerts | Download Current Drug Shortages | Contact Us

Start Over | Back to Previous Screen

Methotrexate Sodium Tablet
Status: Currently in Shortage
»Date first posted: 07/21/2023
»Therapeutic Categories: Rheumatology; Dermatology; Dental; Oncology

Expand all

Accord Healthcare Inc. (Revised 04/17/2024)

Company Contact Information:
866-941-7875, option 2

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Tablet, 2.5 mg (NDC 16729-486-01) Available Stock Available; Inventory shipping to orders

Amneal Pharmaceuticals (Reverified 04/19/2024)

Company Contact Information:
866-525-7270

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Tablet, 2.5 mg (NDC 69238-1423-6) Not commercialized, N/A Demand increase for the drug
Tablet, 2.5 mg (NDC 69238-1423-1) Available Supplying existing customers

Eugia US LLC (Revised 04/25/2024)

Company Contact Information:
888-238-7880

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Methotrexate Sodium, Tablet, 2.5 mg (NDC 59651-182-01) Available

Hikma Pharmaceuticals USA, Inc. (Reverified 04/16/2024)

Company Contact Information:
800-631-2174

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Tablet, 2.5 mg (NDC 0054-4550-25) Available

Mylan Pharmaceuticals Inc., a Viatris Company (Reverified 04/16/2024)

Company Contact Information:
800-796-9526

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Tablet, 2.5 mg (NDC 0378-0014-01) Available On allocation

Sun Pharmaceutical Industries, Inc. (Revised 03/15/2024)

Company Contact Information:
800-818-4555

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Methotrexate Sodium, Tablet, 2.5 mg (NDC 47335-235-83) Available
Methotrexate Sodium, Tablet, 2.5 mg (NDC 47335-235-96) Available

Teva Pharmaceuticals USA, Inc. (Revised 04/26/2024)

Company Contact Information:
800-545-8800

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Methotrexate Tablets, USP, Tablet, 2.5 mg (NDC 0555-0572-02) Limited Availability Estimated Recovery TBD Demand increase for the drug
Methotrexate Tablets, USP, Tablet, 2.5 mg (NDC 0555-0572-35) Available
Trexall, Tablet, 5 mg (NDC 51285-366-01) Available
Trexall, Tablet, 7.5 mg (NDC 51285-367-01) Available
Trexall, Tablet, 10 mg (NDC 51285-368-01) Available
Trexall, Tablet, 15 mg (NDC 51285-369-01) Available

Zydus Pharmaceuticals USA Inc. (Reverified 04/18/2024)

Company Contact Information:
877-993-8779

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Tablet, 2.5 mg (NDC 68382-775-01) Available Available for current customers.
Back to Top